UROV - Urovant Sciences Limited (UROV) CEO Keith Katkin on Q4 2018 Results - Earnings Call Transcript
Urovant Sciences Limited (UROV)
Q4 2018 Earnings Conference Call
June 13, 2019 04:30 PM ET
Company Participants
Christine Ocampo - Senior Vice President and Chief Accounting Officer
Keith Katkin - Chief Executive Officer
Cornelia Haag-Molkenteller - Chief Medical Officer
Michael McFadden - Chief Commercial Officer
Conference Call Participants
Jeet Mukherjee - Jefferies LLC
Ritu Baral - Cowen and Company
Eric Joseph - JPMorgan
Raghuram Selvaraju - H.C. Wainwright & Co, LLC
Presentation
Operator
Ladies and gentlemen, thank you for standing by. Welcome to the Urovant Sciences Fiscal 2018 Fourth Quarter Financial Results Conference Call. At